In vitro studies using muscle cells derived from FSHD patients have shown that ASOs can effectively reduce DUX4 mRNA and protein levels, leading to improved cell survival and reduced cytotoxicity [55]. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.